Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | GMAB | BMRN | ||
| Company | Alnylam Pharmaceuticals | Genmab A/S ADR | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 144.08 | 28.09 | 82.33 | ||
| High | 146.07 | 28.18 | 83.09 | ||
| Low | 143.41 | 27.91 | 81.16 | ||
| Last | 145.37 | 28.11 | 81.64 | ||
| Change | +1.66 | +0.65 | -0.53 | ||
| % Change | +1.16% | +2.37% | -0.65% | ||
| Volume | 188,449 | 182,421 | 896,453 | ||
| 20-Day Average Volume | 476,988 | 391,608 | 1,738,085 | ||
| Previous Close | 143.71 | 27.46 | 82.17 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 148.95 | 29.19 | 88.64 | ||
| 20-Day Raw Stochastic | 18.40% | 22.15% | 4.77% | ||
| 20-Day Relative Strength | 40.85% | 42.68% | 36.28% | ||
| Weighted Alpha | -29.17 | -30.89 | -16.27 | ||
| Today's Opinion | 100% Sell | 100% Sell | 72% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 64% Sell | ||
| Last Month's Opinion | 88% Sell | 24% Sell | 48% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.53% since 04/19/24 | -2.06% since 04/19/24 | -7.94% since 04/19/24 | ||
| Low | 141.98 on 04/25/24 | 27.43 on 04/25/24 | 81.00 on 04/25/24 | ||
| High | 150.27 on 04/23/24 | 29.21 on 04/22/24 | 93.01 on 04/24/24 | ||
| 1-Month | |||||
| %Chg | -4.47% since 03/26/24 | -8.82% since 03/26/24 | -7.01% since 03/26/24 | ||
| Low | 141.98 on 04/25/24 | 27.43 on 04/25/24 | 81.00 on 04/25/24 | ||
| High | 159.34 on 04/09/24 | 30.63 on 03/27/24 | 93.36 on 04/15/24 | ||
| 3-Month | |||||
| %Chg | -19.18% since 01/26/24 | +0.68% since 01/26/24 | -10.21% since 01/26/24 | ||
| Low | 141.98 on 04/25/24 | 26.32 on 02/13/24 | 81.00 on 04/25/24 | ||
| High | 181.66 on 01/30/24 | 31.88 on 03/13/24 | 94.15 on 02/23/24 | ||
| 6-Month | |||||
| %Chg | -6.74% since 10/26/23 | -0.64% since 10/26/23 | -0.46% since 10/26/23 | ||
| Low | 141.98 on 04/25/24 | 26.32 on 02/13/24 | 76.02 on 11/02/23 | ||
| High | 199.38 on 01/09/24 | 32.89 on 11/17/23 | 99.56 on 12/14/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 18,099,698 | 18,157,376 | 15,508,272 | ||
| Shares Outstanding, K | 125,946 | 661,230 | 188,734 | ||
| Annual Sales | 1,828,290,000 | 2,392,030,000 | 2,419,230,000 | ||
| Annual Net Income | -440,240,000 | 631,910,000 | 167,650,000 | ||
| Last Quarter Sales | 439,720,000 | 674,810,000 | 646,210,000 | ||
| Last Quarter Net Income | -137,870,000 | 90,250,000 | 20,380,000 | ||
| 60-Month Beta | 0.39 | 0.99 | 0.31 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.10 on 02/15/24 | 0.36 on 02/14/24 | 0.46 on 04/24/24 | ||
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/24/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 24.13 | 67.56 | ||